Evidence map›Paper›PMID 27466415›Full record

ArticleJournal of virology2016

Characterization of Simian Immunodeficiency Virus Variants Anatomically Compartmentalized in Plasma and Milk in Chronically Infected African Green Monkeys.

Jonathon E Himes, Carrie Ho, Quang N Nguyen, Joshua D Amos, Haolin Xu, Cliburn Chan, Shein-Chung Chow, Christina Ochsenbauer, Zhanna Kaidarova, Sheila M Keating and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Jonathon E HimesDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
Carrie HoDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
Quang N NguyenDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
Joshua D AmosDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
Haolin XuDepartment of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
Cliburn ChanDepartment of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
Shein-Chung ChowDepartment of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
Christina OchsenbauerDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Zhanna KaidarovaBlood Systems Research Institute, San Francisco, California, USA.
Sheila M KeatingBlood Systems Research Institute, San Francisco, California, USA.
Genevieve G FoudaDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
Sallie R PermarDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA sallie.permar@duke.edu.
Duke Medical Center · USBlood Systems Research Institute · USDuke University · USDuke University Hospital · USUniversity of Alabama at Birmingham · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Immune Mechanisms of Severe RSV Disease- T Cell and Antibody ResponsesK23AI067501 · NIAID · UNIVERSITY OF ROCHESTER · PI LEE, FRANCES EUN-HYUNG · 2006 to 2010
$680k
Antibody protection against SIV transmissionR21AI100760 · NIAID · DUKE UNIVERSITY · PI PERMAR, SALLIE R. · 2012 to 2013
$432k
NIAID NIH HHS K23 AI067501NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI064518NIAID NIH HHS R21 AI100760
6 · The paper itself

Abstract

unlabelledUnlike human immunodeficiency virus type 1 (HIV-1)-infected humans, African-origin, natural simian immunodeficiency virus (SIV) hosts, such as African green monkeys (AGMs), sustain nonpathogenic SIV infections and rarely vertically transmit SIV to their infants. Interestingly, chronically SIV-infected AGMs have anatomically compartmentalized SIV variants in plasma and milk, whereas humans and SIV-infected rhesus monkeys (RMs), Asian-origin nonnatural SIV hosts, do not exhibit this compartmentalization. Thus, it is possible that AGM SIV populations in milk have unique phenotypic features that contribute to the low postnatal transmission rates observed in this natural host species. In this study, we explored this possibility by characterizing the infectivity, tropism, and neutralization susceptibility of plasma and milk SIVsab env variants isolated from chronically SIVsab92018ivTF-infected AGMs. AGM plasma and milk SIVsab env pseudovirus variants exhibited similar infectivities, neutralization susceptibilities to autologous and heterologous plasma, and chemokine coreceptor usages for cell entry, suggesting similar abilities to initiate infection in a new host. We also assessed the cytokine milieu in SIV-infected AGM milk and compared it to that of SIV-infected RMs. MIP-1β, granulocyte colony-stimulating factor (G-CSF), interleukin-12/23 (IL-12/23), and IL-13 trended significantly higher in SIV-infected AGM milk than in that of RMs, while IL-18 and IL-6 trended significantly higher in SIV-infected RM milk than in that of AGMs. Taken together, our findings imply that nonviral maternal factors, such as the cytokine milieu, rather than unique characteristics of SIV populations in the milk contribute to the low postnatal transmission rates observed in AGMs. IMPORTANCE: Due to the ongoing global incidence of pediatric HIV-1 infections, including many that occur via breastfeeding, development of effective vaccine strategies capable of preventing vertical HIV transmission through breastfeeding remains an important goal. Unlike HIV-1-infected humans, African green monkeys (AGMs), the natural SIV host species, sustain nonpathogenic SIV infections, rarely transmit the virus postnatally to their infants, and exhibit anatomically compartmentalized SIV populations in milk and plasma. Identifying unique features of the anatomically compartmentalized milk SIV populations could enhance our understanding of how AGMs may have evolved to avoid transmission through breastfeeding. While this study identified limited phenotypic distinctions between AGM plasma and milk SIV populations, potential differences in milk cytokine profiles of natural and nonnatural SIV hosts were observed. These findings imply the potential importance of nonviral factors in natural SIV host species, such as innate SIV/HIV immune factors in milk, as a means of naturally preventing vertical transmission.

Indexed as

Chlorocebus aethiopsAnimalsAntibodies, NeutralizingAntibodies, ViralCytokinesMilkPlasmaSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral TropismVirus InternalizationAntibodies, NeutralizingAntibodies, ViralCytokines

Identifiers

PMID27466415
PMCPMC5021398
OpenAlexW2505056933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.